Home Blog Page 1739

Telix Opens TMS Yokohama in Japan, Commemorative Lecture Held

By
Advertorial Desk
-

MELBOURNE, Australia and KYOTO, Japan, Nov. 21, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the official opening of Telix Manufacturing Solutions (TMS) in Yokohama, Japan, the Company’s first cyclotron facility in the Asia Pacific region (APAC).

TMS Yokohama will enable Telix to provide greater access to radiopharmaceuticals for Japanese patients, initially through clinical supply of TLX250-CDx (a kidney cancer imaging candidate), with plans to supply other Telix investigational and future commercial products, including prostate and brain cancer precision diagnostics and therapies, subject to regulatory approval.

A commemorative lecture was held to mark the occasion, delivered by Professor Jun Hatazawa, Vice President of the Japan Isotope Association and Professor of the Next-Generation Cancer Therapy Research Division at Osaka University, entitled: ‘Trends and Challenges for the Future of Nuclear Medicine’.

Raphael Ortiz, CEO International Business and Japan President at Telix, stated, “The opening of TMS Yokohama is a significant milestone for Telix as it enhances our capacity to meet growing demand for radiopharmaceuticals in Japan and Asia Pacific. As the world’s second-largest nuclear medicine market, we have always considered Japan a key country in our clinical and commercial strategy. Today demonstrates our commitment to the Japanese community, to scientific excellence, and to the well-being of patients throughout the region.”

About Telix Manufacturing Solutions (TMS)

TMS is a global network of 39 manufacturing and distribution facilities across five continents, equipping Telix to deliver commercial and clinical doses to patients globally. Capabilities span isotope production, translational research and radiochemistry, antibody engineering, bioconjugation, and finished radiopharmaceutical manufacturing and distribution. Our TMS Brussels South site with nine GMP lines, clean rooms, a radiopharmacy, and two cyclotrons across a 30,000 sq ft site is one of Europe’s largest radiopharmaceutical production facilities. In the United States, through our RLS network we are delivering more than 2.5 million patient doses annually. Telix’s ARTMS QUANTM Irradiation System® (QIS®) advanced isotope production technology is being deployed at Telix cyclotron facilities worldwide, including select RLS radiopharmacies and TMS Brussels South and Yokohama.

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Visit www.telixpharma.com or jp.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook

Telix Investor Relations (Global)

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2025 Telix Pharmaceuticals Limited. All rights reserved.

AIA Unveils “On Your Side” Critical Illness Protection Series Featuring Multiple First-in-Market Coverages

By
Advertorial Desk
-

Flexible and Precise Protection Solutions Supporting Customer Health Needs at Different Life Stages

  • Introduces On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift # , designed for parents, expectant parents and individuals seeking extensive coverage.
  • Launches Essence – On Your Side Insurance Plan, offering essential critical illness protection for budget-conscious customers.

HONG KONG SAR – Media OutReach Newswire – 21 November 2025 – AIA Hong Kong & Macau announces the launch of its new “On Your Side” Critical Illness Protection Series products, offering customers flexible and caring health protection solutions tailored to the diverse needs across different life stages.

EssenceOnYourSideInsurancePlan en Page 01

According to a survey conducted by AIA@, more than half of the parents and individuals planning to have children are concerned about their children developing childhood cancer. Additionally, more than 40% expressed worries about their children potentially suffering from conditions such as Down Syndrome, Attention Deficit / Hyperactivity Disorder (ADHD). They said their greatest concern is that if their children were unfortunately diagnosed with these illnesses, the high medical and caregiving expenses would become a financial burden.

The On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift # (collectively referred as “On Your Side Insurance Plan 2 series”) covers 115 diseases including critical illnesses, early stage critical illnesses and severe child diseases and provides up to 10 additional claims in total for designated diseases1, with the maximum total benefit reaching up to 1,100% of the Initial Sum Assured2, helping customers face long-term health challenges with greater confidence. To better meet the protection needs of children, the First Gift # edition has been further enhanced with first-in-market* benefits, including Waiver of Premium for Down Syndrome^ and Cord Blood Stem Cell Transfusion Benefit^, offering families more extensive coverage. The series also introduces a first-in-market* Top-up Premium Payment Option11 and Top-up Premium Protector, allowing customers to choose a premium payment option according to their own financial situation at the time of application, thereby enhancing financial flexibility. To further support the insured during critical illness treatment, AIA extends a suite of value-added services to its critical illness insurance products for the first time, including Hong Kong insurance industry-first Care Concierge*3 and One-Stop Oncology Service4, offering multi-faceted health support to help customers navigate their treatment journey with peace of mind.

For budget-conscious customers seeking basic critical illness protection, AIA introduces the Essence – On Your Side Insurance Plan. This plan covers 58 critical illnesses and provides the Big 3 Critical Illness Shield Benefit14, which includes a one-time additional claim for cancer, heart attack or stroke. In addition, additional payment up to 40% of the Initial Sum Assured will be paid as the Prime Age Critical Illness Extra Coverage Booster15 when the Critical Illness Benefit or Big 3 Critical Illness Shield Benefit is paid during the Designated Period15, providing stronger support for the insured during their prime years.

OnYourSideInsurancePlan2 en Page 01

Ms Alice Liang, Chief Proposition & Healthcare Officer of AIA Hong Kong & Macau, said, “Thanks to advancements in medical technology, critical illnesses are no longer necessarily terminal. However, as life expectancy increases, so does the time people may live with illness, and the likelihood of facing multiple critical illnesses over a lifetime. That’s why critical illness protection is no longer optional, but an essential safeguard that stands by customers and their families through prolonged health challenges. The need for sustained financial support has never been greater.

The newly launched flagship On Your Side Critical Illness Protection Series is thoughtfully designed to meet the diverse needs of different customer segments. The On Your Side Insurance Plan 2 series is tailored for those seeking extensive coverage, with the First Gift edition enhancing protection for severe childhood diseases. Through our promotional offer⁵, which includes ‘Personal Medical Case Management Services with Rehabilitation Management’, we help families connect with paediatric care professionals, with an aim to give families greater confidence and peace of mind when facing the unknown.

On the other hand, the Essence – On Your Side Insurance Plan offers essential critical illness protection, with additional coverage for the three major illnesses: cancer, heart attack, and stroke, is ideal for customers who are more budget-conscious and seek value for money.

For the first time, we are also extending value-added services to our critical illness products, delivering personalised medical support that accompanies customers through every step—from diagnosis and treatment to recovery—helping people live Healthier, Longer, Better Lives.”

The promotional offer5 providing complimentary Personal Medical Case Management Services with Rehabilitation Management is available to the eligible insured of On Your Side Insurance Plan 2 – First Gift # for the first two policy years. These services are designed to help families receive prompt support from professional medical teams as needed, along with administrative assistance for access to paediatric services (including private services at the Hong Kong Children’s Hospital16).

AIA has always been committed to caring for children’s physical and mental well-being. Following previous initiatives such as hosting a carnival for patients and their families at the Hong Kong Children’s Hospital and making a donation to support the hospital’s activities, AIA is now further enhancing its health support for children in Hong Kong, demonstrating its long-term commitment to society.

Key Product Features and Value-added Services:

On Your Side Insurance Plan 2 On Your Side Insurance Plan 2 – First Gift
Designed for customers seeking
extensive critical illness protection 		Targeted at expectant mothers aged 18 to 45 and their newborns#
  • Extensive critical illness protection:
    • Covers 115 diseases6: Including 58 critical illnesses, 44 early stage critical illnesses and 13 severe child diseases.
    • ICU Protection Benefit6: Provides 2-tier protection for stays in the Intensive Care Unit (ICU) resulting from health issues beyond critical illnesses (including infectious diseases and injuries).
    • First-in-market* Double Early Stage Critical Illness Payout Benefit6: If the insured is diagnosed with an early stage critical illness at age 65 or above and after the policy is paid up, and if no advance payment has been paid under the policy, an advance payment will be paid as the Double Early Stage Critical Illness Payout Benefit alongside the Early Stage Critical Illness Benefit.
    • 10X Multiple Critical Illness Benefit6: Provides up to 10 additional claims2 in total for cancer, heart attack, stroke, Alzheimer’s disease / Irreversible organic degenerative brain disorders, and Parkinson’s disease.
    • 10% extra cover: For insured aged 18 or above who joins AIA Vitality18 to become a member, the insured will have a 10% extra cover for the first year for life protection or major illness benefit right from the start of the policy of On Your Side Insurance Plan 2.
  • Extensive protection of child diseases: (Only applicable to On Your Side Insurance Plan 2 – First Gift)
    • Caring benefit: First-in-market* Waiver of Premium for Down Syndrome7, first-in-market* Cord Blood Stem Cell Transfusion Benefit8, and Severe Jaundice Benefit9.
    • Five juvenile diseases under Child Development Protector6,10: Angelman Syndrome, Attention Deficit / Hyperactivity Disorder (ADHD), Tourette Syndrome, Marble Bone Disease, and Severe Epilepsy.
  • Flexible financial arrangements:
    • First-in-market* Top-up Premium Payment11 and Top-up Premium Protector6: In addition to the option of paying regular premiums throughout the premium payment term, a top-up premium can also be paid together with regular premiums at policy inception, which will lower the total premiums payable and to be protected under the Top-up Premium Protector in the first 5 policy years.
    • First-in-market* Waiver of Premium on Death (Parents)12: If the policy has been in force for at least 2 years, in the unfortunate event that the parent of an insured child (who must either be the policy owner or contingent owner of the policy) passes away before age 75, the insured child will continue to enjoy the protection under the basic policy without having to pay the balance of regular premiums under the basic policy until the insured child reaches the age of 25.
    • First-in-market* Waiver of Premium on Death (Spouse)13 : If the On Your Side Insurance Plan 2 policy has been in force for at least 2 years, in the unfortunate event that the insured’s spouse, who must be either the policy owner or beneficiary (whether as the sole beneficiary or one of the beneficiaries) of the policy, passes away before age 75, the insured will continue to enjoy the protection under the basic policy without having to pay the balance of regular premiums under the basic policy.
  • Health value-added services: (first extended to AIA’s critical illness insurance products)
    • Hong Kong insurance industry-first Care Concierge* 3: A one-on-one Service Ambassador will provide the eligible insured personalised support throughout their healthcare journey in Chinese Mainland. It covers online family doctor service and medication delivery, as well as seamless, one-stop medical coordination such as Medical Companion Service, Priority Outpatient Booking Service, and Priority Inpatient Booking Service, as well as medical home visit service for the eligible insured’s parents.
    • One-Stop Oncology Service4: It connects the eligible insured to integrated oncology treatments and services in Hong Kong. A dedicated Service Ambassador will guide the eligible insured throughout the journey – connecting them with a multi-disciplinary team of medical specialists, and consolidating the proposed treatment plan and estimated medical expenses.
Essence – On Your Side Insurance Plan
Designed for budget-conscious customers seeking essential critical illness protection
  • 1+1 Health Shield Integration: Covers 58 critical illnesses6. It also provides the Big 3 Critical Illness Shield Benefit14, which includes a one-time additional claim for cancer, heart attack or stroke.
  • Extra Coverage Booster: Additional payment up to 40% of the Initial Sum Assured will be paid as the Prime Age Critical Illness Extra Coverage Booster15 when the Critical Illness Benefit or Big 3 Critical Illness Shield Benefit is paid during the Designated Period15. In the event of the death of the insured, an additional payment of up to 40% of the Initial Sum Assured will be made to the beneficiary of the policy under the Whole Life Extra Coverage Booster for Death17.
  • Rare-in-market Extension of Grace Period Benefit18: The grace period for late premium payment can be extended from 31 days to up to 365 days if one of the specified events occurs to the policy owner during the premium payment term, including involuntary unemployment, marriage, parenthood, divorce, relocation or purchasing a residential property.
  • Health value-added services (first extended to AIA’s critical illness insurance products): One-Stop Oncology Service4 connects the eligible insured to integrated oncology treatments and services in Hong Kong. A dedicated Service Ambassador will guide the eligible insured throughout the journey – connecting them with a multi-disciplinary team of medical specialists, and consolidating the proposed treatment plan and estimated medical expenses.
  • 10% extra cover: For insured aged 18 or above who joins AIA Vitality19 to become a member, the insured will have a 10% extra cover for the first year for life protection or major illness benefit right from the start of the policy of Essence – On Your Side Insurance Plan.

All information above is for reference only and does not constitute any offer and/or insurance product recommendation. The product information in this material does not contain the full terms of the policy, for the details of the product features, terms and conditions, exclusions and key product risks, please refer to the product brochure and policy contract of relevant products or visit the AIA Hong Kong’s website. In case you want to read policy contract sample before making an application, you can obtain a copy from AIA. Life insurance policies are long-term contracts of insurance. Should you surrender the policy early, you may receive an amount considerably less than the total amount of premiums paid. You may choose to purchase the above Plan(s) as a standalone plan without purchasing other type(s) of insurance products at the same time.

Remarks:

*
Regarding the first-in-market statement in:

  • “Double Early Stage Critical Illness Payout Benefit”, “Waiver of Premium for Down Syndrome”, “Cord Blood Stem Cell Transfusion Benefit” and “Top-up premium with Top-up Premium Protector”, as of 23 July 2025, compared against critical illness products provided by major Hong Kong insurance companies.
  • “First Gift” was pioneered by AIA in the Protect Elite Ultra 2 on 30 January 2019, compared against critical illness products provided by major Hong Kong insurance companies.
  • “Waiver of Premium on Death (Parents)” and “Waiver of Premium on Death (Spouse)” were pioneered by AIA in the Protect Elite Ultra on 1 May 2018, compared against critical illness products provided by major Hong Kong insurance companies.

Regarding the “Hong Kong insurance industry-first” statement in “Care Concierge”, as of 31 January 2024, compared against similar services offered by major Hong Kong insurance companies.

#
“First Gift edition” refers to “On Your Side Insurance Plan 2 – First Gift”. The proposed insured of the On Your Side Insurance Plan 2 – First Gift policy must be an expectant mother who (i) must be aged 18 to 45 with gestation period of 22nd week or above at the time of application for the On Your Side Insurance Plan 2 – First Gift policy and (ii) carries the fetus for herself and who will become the legal mother of the newborn child following his/her birth. Only 1 person can be the insured under the On Your Side Insurance Plan 2 – First Gift policy at any given time. The expectant mother is required to apply for a separate On Your Side Insurance Plan 2 – First Gift policy for each fetus if she is carrying twins. On Your Side Insurance Plan 2 – First Gift is not applicable to an expectant mother who is carrying more than two fetuses at the same time. The issuance of the On Your Side Insurance Plan 2– First Gift policy is subject to AIA’s sole discretion and underwriting decision.
^
Only applicable to On Your Side Insurance Plan 2 – First Gift.
&
The insured of the On Your Side Insurance Plan 2 – First Gift policy must have been changed from the expectant mother to the newborn child before AIA will process any claims related to the newborn child under the policy. The policy owner shall notify AIA of the birth of the newborn child and provide a certified true copy of the newborn child’s birth certificate as soon as possible and by 14 days before the first policy anniversary, otherwise the policy will terminate on the first policy anniversary and the insured will lose the cover.
@
AIA conducted an online survey in August 2025 among 1,000 Hong Kong residents aged 18 to 65.
1.
Once the total advance payments paid under the policy reach 100% of the Initial Sum Assured, subject to the relevant waiting period, the 10X Multiple Critical Illness Benefit will pay up to 10 additional claims in total for cancer, heart attack, stroke, Alzheimer’s disease / Irreversible organic degenerative brain disorders and Parkinson’s disease. The cover period of the 10X Multiple Critical Illness Benefit is up to age 85 of the insured. Each claim payment under the 10X Multiple Critical Illness Benefit is equivalent to 100% of the Initial Sum Assured. In order to be eligible for a claim payment under the 10X Multiple Critical Illness Benefit, (a) heart attack must be newly diagnosed and must relate to a separate cardiac incident, and (b) stroke must be newly diagnosed and must relate to a separate cerebrovascular accident or incident, producing new findings of new or increased neurological functional impairment.

Together with the claim under Critical Illness Benefit, the maximum number of claims under the policy for the following diseases cannot exceed the following limitations:

  • Cancer: 6 claims.
  • Heart Attack and Stroke: 3 claims in total, with a maximum of 2 claims for Heart Attack and 2 claims for Stroke.
  • Alzheimer’s disease / Irreversible organic degenerative brain disorders and Parkinson’s disease: 1 claim.
2.
Total benefits payable per policy (under major illness benefit and 10X Multiple Critical Illness Benefit):

  • For cancer (under major illness benefit, Continuous Cancer Income Option and 10X Multiple Critical Illness Benefit), total benefits cannot exceed 600% of Initial Sum Assured.
  • For heart attack and stroke, total benefits cannot exceed 300% of Initial Sum Assured.
  • For Alzheimer’s disease / Irreversible organic degenerative brain disorders and Parkinson’s disease, total benefits cannot exceed 100% of Initial Sum Assured. Only 1 claim can be made for either Alzheimer’s disease / Irreversible organic degenerative brain disorders or Parkinson’s disease under each policy.
3.
Care Concierge is an additional value-added service of On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift, which is not guaranteed and subject to the respective terms and conditions thereof, and does not form part of the contractual benefit of On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift. AIA reserves the right to amend, suspend or terminate Care Concierge or any part of the service thereunder (including the service providers, any details or terms and conditions relating thereto) at any time without any prior notice. The services under Care Concierge are provided in Chinese Mainland by the designated third-party service provider engaged by AIA and not applicable to Hong Kong and Macau region. Please note that the Pre-approval – Medical Expense & Cashless Service and the relevant administrative support under Care Concierge as set out in the leaflet of Care Concierge are not available to be used by the insured of On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift. For details and the terms and conditions thereof, please refer to the relevant service leaflet and AIA’s website: https://www.aia.com.hk/en/health-and-wellness/healthcare-services/care-concierge
4.
One-Stop Oncology Service is additional value-added service of On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift and Essence – On Your Side Insurance Plan , which is not guaranteed, and subject to its terms and conditions thereof, and does not form part of the contractual benefit of On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift, or Essence – On Your Side Insurance Plan. AIA reserves the right to amend, suspend or terminate One-Stop Oncology Service or

any part of the service thereunder (including the service providers, any details or terms and conditions relating thereto) at any time without any prior notice. One-Stop Oncology Service is provided in Hong Kong by the designated third party service provider engaged by AIA and not applicable to Macau region. The multi-disciplinary team of the medical specialists under One-Stop Oncology Service is designated by independent third party service provider and is subject to change from time to time without prior notice. Please note that the Pre-approval – Medical Expense & Cashless Service and the relevant administrative support under One-Stop Oncology Service as set out in the service leaflet of One-Stop Oncology Service are not available to be used by the insured of On Your Side Insurance Plan 2 / On Your Side Insurance Plan 2 – First Gift, or Essence – On Your Side Insurance Plan. For details, please refer to the service leaflet and AIA’s website at https://www.aia.com.hk/en/health-and-wellness/healthcare-services/aia-carepass/one-stop-oncology-service

5.
The promotional offer of On Your Side Insurance Plan 2 – First Gift (“Promotional Offer”) is available upon successful application of On Your Side Insurance Plan 2 – First Gift within the promotional period from 23 September 2025 to 31 March 2026 and fulfilment of the relevant conditions, including a minimum initial sum assured of US$50,000 at policy issuance. The Promotional Offer is subject to its terms and conditions. For details and the terms and conditions thereof, please refer to the promotional leaflet: https://www.aia.com.hk/content/dam/hk-wise/pdf/campaign-and-events/en/oys2-promotion-leaflet-en.pdf

The Personal Medical Case Management Services with Rehabilitation Management (“PMCM Services”) under the Promotional Offer are available to the eligible insured of On Your Side Insurance Plan 2 – First Gift for use within the first 2 policy years from the issue date of the eligible policy of On Your Side Insurance Plan 2 – First Gift as shown on the policy information page of such policy. The PMCM Services are subject to the eligibility of the insured, including the evaluation of the insured’s medical conditions. The PMCM Services, including the administrative support in accessing to paediatric care of the Hong Kong Children’s Hospital, are provided in Hong Kong by the designated independent third-party service provider engaged by AIA and are not applicable to Macau Region. Please note that the provision of any services by the Hong Kong Children’s Hospital is not part of the PMCM Services and is subject to the review and assessment of conditions of the insured by the Hong Kong Children’s Hospital. AIA shall not be responsible or liable for any medical service, product and solicitation effort provided by the designated independent third-party service provider or the Hong Kong Children’s Hospital, which is not sold or marketed by AIA.

The PMCM Services are subject to its availability and the relevant terms and conditions of (i) the Promotional Offer as set out in the leaflet of the Promotional Offer and the notification letter issued by AIA notifying the entitlement of the Promotional Offer (upon fulfilment of all the requirements of the Promotional Offer), and (ii) the PMCM Service as set out in the service leaflet and as imposed by the service provider of the PMCM Services. For details of the PMCM Services, please refer to the service leaflet and AIA’s website at https://www.aia.com.hk/en/health-and-wellness/healthcare-services/personal-medical-case-management-services/what-is-personal-medical-case-management), and contact the service provider.

6.
Subject to relevant conditions. For details, please refer to the relevant product brochure.
7.
If the insured child is diagnosed with Down Syndrome, and if the result of the Non-Invasive Prenatal Test (NIPT) conducted by the expectant mother during gestation for Down Syndrome was low risk or low probability, we will waive the balance of regular premiums payable under the On Your Side Insurance Plan 2 – First Gift basic policy.
8.
  • If the insured child is diagnosed with cancer for which the major illness benefit or 10X Multiple Critical Illness Benefit is paid or payable in respect of such cancer; and
  • If Cord blood stem cell transfusion is medically necessary for treatment of such cancer as recommended by a registered medical practitioner who is an oncologist and the insured is under the age of 18 when he / she receives cord blood stem cell transfusion,

additional 10% of Initial Sum Assured will be paid, subject to a maximum per life limit of US$35,000. This benefit can be paid once only under the policy.

9.
If the insured child is born on or after 37 weeks of gestation and suffers from severe jaundice, and if in-patient phototherapy for treatment of such severe jaundice is medically necessary for at least 5 consecutive days and within 30 days after birth, an additional 0.1% of Initial Sum Assured will be paid for each day of confinement, subject to a maximum limit of US$250 per day per life, up to a maximum of 7 days. This benefit can be paid once only under the policy.
10.
Under the coverage of Child Development Protector, the insured child will be covered until he / she reaches age 18.
11.
The Top-up Premium Payment Option can only be selected at policy application, and it is only available to policies with annual premium payment mode selected (the payment mode can be changed after the first policy anniversary). The amount of top-up premium for a policy is determined by AIA and cannot be adjusted on individual basis. Once top-up premium payment option is selected, it cannot be cancelled or changed. For the differences between these two premium payment options (including returns, benefits and premium amounts), please refer to the respective benefit illustrations.
12.
The Waiver of Premium on Death (Parents) is applicable to (i) On Your Side Insurance Plan 2 – First Gift policy and (ii) On Your Side Insurance Plan 2 policy with insured under the age of 18 at the time of policy application. The parent of the insured child must be aged 50 or below at the time of policy application.
13.
The Waiver of Premium on Death (Spouse) is applicable to On Your Side Insurance Plan 2 policy with insured aged 18 or above at the time of policy application. The insured’s spouse must be aged 50 or below at the time of policy application.
14.
After the total advance payments paid under the policy has reached 100% of the Initial Sum Assured, subject to the relevant waiting period, the Big 3 Critical Illness Shield Benefit will pay 1 additional claim for cancer, heart attack or stroke. The claim payment under the Big 3 Critical Illness Shield Benefit is equivalent to 100% of the Initial Sum Assured. The cover period of the Big 3 Critical Illness Shield Benefit is up to age 85 of the insured. In order to be eligible for a claim payment under the Big 3 Critical Illness Shield Benefit, (a) heart attack must be newly diagnosed and must relate to a separate cardiac incident, and (b) stroke must be newly diagnosed and must relate to a separate cerebrovascular accident or incident, producing new findings of new or increased neurological functional impairment. In case the insured reaches the age of 70 or above and makes any subsequent claim for prostate cancer resulting from the continuation of a previous prostate cancer for which a previous claim was made under the policy, the Big 3 Critical Illness Shield Benefit will only be payable for the subsequent claim for prostate cancer if the insured has received or is in the process of receiving the full course of cancer-directed surgery, radiotherapy, chemotherapy, targeted therapy or a combination of these treatments (excluding hormonal therapy) which is medically necessary as recommended by a registered medical practitioner during the intervening period between the diagnosis of the previous and subsequent prostate cancer.
15.
Designated Period refers to the period starting from the policy effective date until the later of (i) the day before the policy anniversary on or immediately following the insured’s 70th birthday; and (ii) the end of the 10th policy year.

The amount of Prime Age Critical Illness Extra Coverage Booster payable is subject to the following:

  1. If major illness benefit is paid, 100% of the Extra Coverage Booster Amount (i.e. 40% of the Initial Sum Assured) will be paid. AIA will deduct payment made under the Prime Age Critical Illness Extra Coverage Booster for minor illness before paying the Prime Age Critical Illness Extra Coverage Booster for major illness.
  2. If minor illness benefit is paid, 50% of the Extra Coverage Booster Amount (i.e. 20% of the Initial Sum Assured) will be paid.
  3. If Big 3 Critical Illness Shield Benefit is paid, 100% of the Extra Coverage Booster Amount (i.e. 40% of Initial Sum Assured) will be paid.
16.
According to information from the Hong Kong Children’s Hospital, the Hong Kong Children’s Hospital specialises in complex, serious and uncommon paediatric cases requiring multidisciplinary management. It provides diagnosis, treatment and rehabilitation for patients with relevant clinical needs from birth to 18 years of age. Apart from public services, the Hong Kong Children’s Hospital also provides limited private services. All patients have to be referred by registered doctors in public hospitals or the private sector. (Source: https://www31.ha.org.hk/hkch/Patients/PrivateService)
17.
The amount of Whole Life Extra Coverage Booster for Death will be reduced to 50% of the Extra Coverage Booster Amount (i.e. 20% of the Initial Sum Assured) if Prime Age Critical Illness Extra Coverage Booster has been paid for minor illness. The Whole Life Extra Coverage Booster for Death will be terminated upon the earlier of (a) payment(s) paid under the Prime Age Critical Illness Extra Coverage Booster reach 100% of the Extra Coverage Booster Amount (i.e. 40% of the Initial Sum Assured) and (b) the Big 3 Critical Illness Shield Benefit is payable under the basic policy.
18.
Regarding the rare-in-market statement for Extension of Grace Period Benefit: As of 13 August 2025, compared with critical illness insurance products provided by Hong Kong major insurance companies.

Application for the Extension of Grace Period Benefit is subject to submission of required documentary proof, AIA’s approval and its prevailing rules and conditions.

19.
AIA Vitality is not an insurance product, and an annual membership fee is required for joining.

Hashtag: #AIAHongKong

The issuer is solely responsible for the content of this announcement.

About AIA Hong Kong & Macau

AIA Group Limited established its operations in Hong Kong in 1931. To date, AIA Hong Kong and AIA Macau have about 18,000 financial planners1, as well as an extensive network of independent financial advisors, brokerage and bancassurance partners. We serve over 3.6 million customers2, offering them a wide selection of professional services and products ranging from individual life, group life, accident, medical and health, pension, personal lines insurance to investment-linked assurance schemes with numerous investment options. We are also dedicated to providing superb product solutions to meet the financial needs of high-net-worth customers.

1 As at 30 June 2025
2 Including AIA Hong Kong and AIA Macau’s individual life, group insurance and pension customers (as at 30 June 2025)

Resilience Strategies for Importers and Exporters in Volatile Markets: Tradewind Seminar in Hong Kong Supports Sustainable Growth

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 21 November 2025 – To help importers and exporters navigate an increasingly complex global trade environment, Tradewind Finance hosted a seminar today at the Hong Kong General Chamber of Commerce titled “Resilience Strategies for Importers and Exporters: Managing Cash Flow and Credit Risk in a Volatile Market.”

The event brought together Ebury, a specialist in foreign exchange risk management, and Dun & Bradstreet, a global leader in data and analytics. Speakers addressed the impact of geopolitical tensions, FX volatility and buyer credit risk, and shared practical tools and comprehensive solutions to strengthen financial resilience.

In the presentation, “From Payment Delays to Growth Capital: Creating a Perfect Cash Flow Solution for Importers and Exporters,” Jimmy Zhu, Assistant Vice President of Sales at Tradewind, outlined the pressures businesses facing today. He noted that ongoing tariff disputes, more volatile trade flows, market diversification and rising buyer insolvencies are lengthening receivables cycles, tightening bank lending conditions and increasing cash-flow strain.

To address these challenges, Jimmy presented Tradewind’s tailor-made factoring solutions. Following shipment, Tradewind can advance up to 90% of the invoice value within 48 hours, easing working capital pressure. The company also provides buyer credit assessments, receivables collection services and flexible credit limits, helping companies optimize payment terms and reduce transaction risk. These services already cover markets including the United States, the Middle East and Hong Kong, and are particularly suitable for companies with multiple international entities whose funding needs exceed what traditional bank financing can provide.

Kary Kung, Head of Sales & Partnerships at Ebury, spoke on how FX volatility can erode corporate profit margins. She reviewed 2025 FX market trends and settlement strategies in the context of “de-dollarization.” Using case studies, she demonstrated how forward contracts and layered hedging can lock in FX costs, while global collection accounts and localized payment solutions improve capital efficiency and enhance the competitiveness of export pricing.

During the panel discussion, representatives from Tradewind, Ebury, and Dun & Bradstreet highlighted the role of collaboration among financial institutions in proactive risk management. Charmaine Wong, Vertical Leader, Hong Kong Client Management at Dun & Bradstreet, explained that by leveraging global commercial data and behavioral risk analytics, companies can more accurately assess the creditworthiness of buyers in Europe and the United States and reduce transaction risk at its source.

By combining Tradewind’s rapid financing, Ebury’s FX hedging solutions, and Dun & Bradstreet’s credit insights, the firms presented an end-to-end framework that integrates credit assessment, funding protection and FX hedging, enabling businesses to identify opportunities in volatile markets and pursue sustainable growth.

The seminar attracted nearly 100 corporate representatives from manufacturing, trade, wholesale and logistics. Tradewind stated that it will continue to work with ecosystem partners to provide localized, structured financial and risk-management support to importers and exporters in Hong Kong and across Asia, helping clients build lasting resilience and growth momentum in global markets.

Hashtag: #Tradewind #tradefinance #finance #exportfactoring #financing #invoicediscounting #invoicefinancing



Wechat: 德益世国际保理

The issuer is solely responsible for the content of this announcement.

Tradewind Finance

Tradewind Finance, founded in 2000 and headquartered in Germany, specializes in international trade finance. Our one-stop solutions help importers and exporters accelerate cash conversion, optimize cash flow, reduce risk and support the expansion of global trade.

With a worldwide network and a multilingual team of specialists, Tradewind serves clients around the world. Drawing on 25 years of expertise in trade and finance, the company delivers customized financing solutions to businesses across more than 20 industries.

Taiwan Smart Security Alliance Launches “ACI Defense: Security and Rescue” Brand in Thailand

By
Advertorial Desk
-

TAIPEI, TAIWAN – Media OutReach Newswire – 21 November 2025 – In recent years, the Thai government has been actively promoting smart city development and the Eastern Economic Corridor (EEC) initiative. As Bangkok ranks among the world’s top international tourist destinations, issues such as the prevalence of firearms and persistent armed conflicts in southern Thailand have created an urgent need for disaster prevention and crime control. To address these challenges, the Taiwan Smart Security Alliance integrated 11 Taiwanese companies specializing in software, hardware, AIoT, big data, edge computing, geospatial data, and cloud services, and jointly launched the smart security brand “ACI Defense: Security and Rescue.”

Taiwan Smart Security Alliance Launches “ACI Defense: Security and Rescue” Brand in Thailand

By applying AI-based image analytics and other intelligent technologies, the alliance offers two major categories of solutions: “Urban Monitoring” and “Disaster Prevention Simulation.” Its core products include a real-time crime hotspot analysis system, a 3D disaster simulation platform, anti-terror drone surveillance, and a VR firefighting training platform, which aims to help the partners develop more flexible, integrated solutions and escape the low-margin, single-product export trap.

With support from the Taiwanese government, the alliance has launched a brand website, promoted social media content, and organized high-impact marketing events in Thailand. These efforts have been further strengthened by international media exposure and the establishment of a local demonstration center. Through these initiatives, the alliance has successfully partnered with Thai system integrators to introduce surveillance and security solutions, generating business opportunities valued at around US$3.16 m.Hashtag: #TaiwanInnovativeSoftwareandServicesAssociation

The issuer is solely responsible for the content of this announcement.

Hon Hai Tech Day 2025 Opens To Showcase Foxconn’s Powerful Partnerships And Vertical Integration Strengths

By
Advertorial Desk
-

NVIDIA, OpenAI, Alphabet, IBM, ABB Robotics, Uber, FUSO Participate Onstage

TAIPEI, Nov. 21, 2025 /PRNewswire/ — Accelerating its transformation into an AI-powered technology platform service company, Hon Hai Technology Group (“Foxconn”) (TWSE: 2317) on Friday welcomed powerful partnerships, including NVIDIA, OpenAI and Alphabet, and shared its unrivalled strength in vertical integration at its annual flagship technology conference, Hon Hai Tech Day 2025.

The speed and progress of the world’s largest electronics manufacturer in the fields of supercomputing, smart manufacturing, intelligent electric vehicles and more came into focus as global AI, tech and automotive bellwethers – in a line-up also spotlighting IBM, ABB Robotics, Uber and Mitsubishi Fuso Truck and Bus Corp – took to the stage on opening day of HHTD25.

“Our competitive strength is vertical integration. Our technological depth and manufacturing heritage enables deep collaborations with world-class technology leaders, partners who rely on us because they know that Foxconn can turn ideas into reality – quickly, reliably and at scale,” said Foxconn Chairman Young Liu. “It positions us well as we push into frontier technologies paved open by AI and quantum.”

OpenAI CEO Sam Altman spoke for the first time about the significance of a new partnership with Foxconn: “Demand for critical components for AI infrastructure is already far outpacing supply and we expect that will only continue over the coming years. This agreement is about strengthening supply chains to meet existing and future needs across the industry,” Altman said via video.

Another powerful partner, Alphabet Chief Product Officer of Other Bets, Hiroshi Lockheimer, said via video, “Foxconn is an important partner to Google and Alphabet, and our collaboration has helped bring to life some of the most important technological innovations of the past decade.”

Foxconn, a Taiwan NVIDIA Cloud Partner, known as NCP, is investing US$1.4 billion in an advanced supercomputing center, accelerated by 10,000 NVIDIA Blackwell Ultra GPUs, that will be utilizing next-generation NVIDIA GB300 NVL72 AI infrastructure in the first half 2026.

It would make it among the first in Asia to use the most advanced NVIDIA Blackwell platform, said Neo Yao, CEO of Foxconn subsidiary Visionbay, which is leading the project. Yao discussed the pathway for revolutionary AI factories alongside Alexis Bjorlin, Vice President of NVIDIA DGX Cloud, in the first of two morning talks featuring NVIDIA executives on topics of AI-powered supercomputing and robotics.

The roadmap to humanoids in Smart Manufacturing – from simple and fixed; to simple but flexible; to complicated but flexible – and how quantum technologies can have the potential to elevate future AGI to another level, came under discussion.

On display at HHTD25’s bigger than ever exhibition area were over 200 products and technologies. A model of an AI-ready modular container data center installed with GB300 AI infrastructure was set up for the first time at HHTD25 exhibition area, demonstrating unrivalled turnkey solutions, covering L1 to L12 manufacturing and strong vertical integration capabilities.  

Presented for the first time on the HHTD25 stage, the MODEL A is a B-segment class EV, combining artificial intelligence technology and modular versatility to bring diverse application scenarios to a single reference electric vehicle.

Among EV reference vehicles, six MODEL B’s, some in never before seen colors on the crossover; three unique reference styles of the MODEL A; the award-winning MODEL T electric bus built with Foxconn motor and battery; the midi-size MODEL U for shuttle use; the LMUV MODEL D; and North American variant of the family SUV MODEL C were parked for viewing throughout the HHTD25 hall.

HHTD25 runs from November 21-22 at the Taipei Nangang Exhibition Center, Hall 1, 4F.

For more on Hon Hai Tech Day 2025 here.

About Foxconn here.

China Southern Power Grid Marks Its First Delegation Appearance at COP30, Showcasing Sustainability and Low-Carbon Initiatives

By
Advertorial Desk
-

CSG Demonstrates Its Commitment to Global Climate Action through Practical Low-Carbon Solutions

BELÉM, Brazil, Nov. 21, 2025 /PRNewswire/ — China Southern Power Grid (CSG) participated in the 30th Conference of the Parties to the United Nations Framework Convention on Climate Change (COP30), held in Belém, Brazil, from November 10 to 21. During the conference, the company hosted a series of events on November 19 at the China Pavilion, themed “Forge a New Chapter for Green Power Grid, Lay the Foundation for a World-Class Enterprise.”

Global Guests Converge on CSG's COP30 China Pavilion Event
Global Guests Converge on CSG’s COP30 China Pavilion Event

On “Corporate Day,” CSG, together with China National Petroleum Corporation and China Energy Investment Group Co., co-hosted a side event, bringing together representatives from governments, businesses, and research institutions across multiple countries. Participants discussed how all stakeholders can support China’s dual-carbon goals and strengthen global climate governance. A CSG executive delivered a keynote speech outlining the company’s progress in developing a next-generation power system and supporting the clean energy transition. The executive also chaired an international roundtable on low-carbon and sustainable development, where participants from Brazil, Peru, and other countries explored collaborative approaches to accelerate low-carbon industrial development.

On the same day, CSG also organized a special session titled “New Practices of Eco-Oriented Enterprises in Advancing Green and Low-Carbon Development”. During the event, the company released the China Southern Power Grid Eco-Oriented Enterprises Report in Chinese and English, offering a clear overview of its strategy for supporting the shift to renewable energy. The session also highlighted topics including carbon target management, zero-carbon industries, and CSG’s international low-carbon business activities. Through case studies, a themed exhibition, and an interactive tea-making demonstration powered by clean electricity, CSG showcased its innovation and practical work to strengthen environmental performance and support low-carbon development. Throughout COP30, CSG’s exhibition on ecological stewardship and promotional video were continuously displayed at the China Pavilion, highlighting how Chinese companies are contributing to global climate action and technological progress.

FIT Hon Teng Showcases at Hon Hai Tech Day, Demonstrating the Foxconn’s Vertical Integration Strength

By
Advertorial Desk
-

HONG KONG, Nov. 21, 2025 /PRNewswire/ — Hon Hai Tech Day will take place on November 21–22 at the Nangang Exhibition Center, spotlighting “The Real-World Applications of Hon Hai’s Three Major Intelligent Platforms Combined with AI Technologies.” The event will fully showcase the Group’s latest advances in AI innovation.

FIT Hon Teng (6088.HK), a subsidiary of Hon Hai Precision Industry Co., Ltd. (2317-TW) specializing in connector manufacturing, will present a comprehensive lineup of high-speed connectors, power solutions, and liquid-cooling technologies, highlighting the advantages of the Foxconn Group’s vertically integrated ecosystem.

This year, FIT is exhibiting high-speed server interconnects, power delivery solutions, and liquid-cooling products, including the 800V & ±400V Power Busbar for high-voltage systems, the 400A & 100A AC Whip Connectors and the 140kW LC Busbar & UQDB Floating Module for high-current applications. Among them, the 400A AC Whip Connector is the first of its kind in the market, designed to meet emerging requirements for high-power server racks. These technologies drew strong interest from leading CSP R&D teams and key customers during their debut at OCP, and FIT’s LC Busbar and Power Busbar were successfully integrated into the NVIDIA MGX showcase wall.

Hon Hai Tech Day will be held on November 21–22 at the Nangang Exhibition Center in Taipei, featuring the Group’s latest technological achievements and industry collaboration initiatives. FIT sincerely invites industry partners, media, and the public to visit the exhibition and witness the newest developments of the Hon Hai Technology ecosystem.

For more information about Hon Hai Tech Day (HHTD), please visit the official Hon Hai website: HHTD – Hon Hai Tech Day.

About Foxconn Interconnect Technology (FIT Hon Teng)

Foxconn Interconnect Technology (HKEX: 6088) was listed on the Hong Kong Stock Exchange in 2017 and is the largest consumer electronics connector manufacturer in Greater China. While connectors remain its core business, the company has strategically expanded in recent years into 5G AIoT, electric vehicles, and acoustic electronic components, while also entering the consumer brand sector. For more information, please visit the company’s website at www.fit-foxconn.com

Media Contact:                                     Product and Service Inquiries:

Email: fit-ir@fit-foxconn.com            Europe and America Contact: sales-usa@fit-foxconn.com  

Sunway University and Elitery Sign Memorandum to Explore AI in Education

By
Advertorial Desk
-

PETALING JAYA, Malaysia, Nov. 21, 2025 /PRNewswire/ — Sunway University and Elitery, a leading Indonesian provider of managed cloud and security solutions, announced today that they have signed a nonmonetary, nonbinding memorandum of understanding (MoU) to explore collaboration in artificial intelligence (AI) and digital learning. The MoU establishes a framework for good faith discussions and does not create legal or financial obligations.

Sunway University and Elitery
Sunway University and Elitery

Under the MoU, the parties intend to explore collaboration in four areas:

  • Educational technology innovation: investigating intelligent learning systems that may support educators and enhance student outcomes.
  • Research and innovation: identifying joint research projects on emerging education technologies and discussing opportunities for global publications and showcases.
  • Capacity building: exploring potential training and upskilling initiatives for students, faculty and researchers to strengthen practical expertise in AI and digital tools.
  • Knowledge exchange: considering cobranded seminars, conferences and workshops to share best practices and promote the adoption of AI-driven education in Malaysia and the wider region.

Professor Malissa Maria Mahmud, Dean of the School of Education at Sunway University, welcomed the collaboration. “At Sunway University, we see technology as a critical enabler for education. This MoU allows us to explore how AI can enrich teaching and learning while ensuring our educators and students acquire the skills needed for a digital economy. It gives us the flexibility to identify and co-create initiatives that genuinely benefit our learners and partners,” she said.

Kresna Adiprawira, President Director of Elitery, added, “Education has always been at the heart of Elitery’s innovation journey. Over the years we have partnered with schools, universities and government institutions to introduce digital solutions that make learning more accessible and impactful. Through this collaboration we hope to explore how AI can support futureready talent and contribute to Malaysia’s digital economy.”

Elitery serves as the first strategic partner in advancing AI in the Sunway University, Malaysia. The MoU is intended to guide discussions for an initial period of three years. Any specific projects or programmes arising from these discussions will be developed under separate agreements.

About Sunway University

Sunway University, one of Malaysia’s top private institutions, is globally ranked by QS and named #1 private university in ASEAN by AppliedHE 2025. It is also the #1 non-government linked private university in ASEAN by Times Higher Education (THE) World University Rankings 2026. For the fourth-year running, Sunway leads in Graduate Employability in Malaysia, according to Talentbank’s National Graduate Employability Index.

About Elitery

Listed on the Indonesia Stock Exchange (ticker: ELIT), PT Data Sinergitama Jaya Tbk (Elitery) is an Indonesian IT managed services provider specialising in managed cloud and managed security solutions. As a certified Managed Services Provider, Elitery helps enterprises and public sector organisations modernise and protect their digital infrastructure, covering planning, migration, implementation, monitoring and incident response. Elitery has been certified as a Great Place to Work® and has established Elitery Global Technology Sdn. Bhd. in Malaysia to support regional digital transformation.

1...1,7381,7391,740...6,465Page 1,739 of 6,465